Preventive Effect of l-Carnitine on Scar Formation During Acute Pyelonephritis: A Randomized Placebo-Controlled Trial

(2020) Preventive Effect of l-Carnitine on Scar Formation During Acute Pyelonephritis: A Randomized Placebo-Controlled Trial. American Journal of Therapeutics. E229-E234. ISSN 1075-2765

Full text not available from this repository.

Abstract

Background: Urinary tract infection and pyelonephritis are clinical problems that frequently occur in children. Several factors are responsible for renal tissue injury, morbidity, and renal scarring after pyelonephritis. The aim of this study was to evaluate the preventive effect of l-carnitine on renal scarring in acute pyelonephritis. Methods: A randomized double-blind clinical trial was conducted on 65 children aged 6 months to 10 years. Patients were randomized into 2 groups to receive 7-day treatment with only antibiotics without l-carnitine (control group; n = 32) and 7-day treatment with l-carnitine (case group; n = 33) during the acute phase of infection. Technetium-99m-labeled dimercaptosuccinic acid (DMSA) scintigraphy was performed for all children during the acute phase (in 2-7 days of hospitalization) and late phase. P-value less than 0.05 was statistically significant. Results: We recruited 65 participants in the study: 32 children in control group and 33 children in case group. Three children in the control group and 2 children in the case group refused to perform the second DMSA scan. Overall, data analysis at the end of the study was done on 60 patients. Age distribution of girl patients with upper urinary infection was 6.5 in girl children aged between 6 months and 12 months, 41.1 aged between 1 and 5 years, 33.3 aged between 5 and 10 years, respectively. There was no significant difference between 2 groups in age and sex. There was no significant difference between 2 groups in systolic blood pressure, diastolic blood pressure, the lab data including urine white blood cells and serum erythrocyte sedimentation rate, and antibiogram profiles. Voiding dysfunction was detected in 10 of the participants. The baseline DMSA was not significantly difference in 2 groups, but worsening of kidney lesions was significantly higher in control group after 6 months (P = 0.012). Conclusion: Our study showed that l-carnitine significantly decreased renal scarring because of acute pyelonephritis.

Item Type: Article
Keywords: DMSA pyelonephritis scar formation l-carnitine URINARY-TRACT-INFECTION VITAMIN-E ASCENDING PYELONEPHRITIS RENAL-FAILURE CHILDREN ANTIOXIDANT DEFECTS REFLUX KIDNEY INJURY
Subjects: WJ Urogenital System
Divisions: Cardiovascular Research Institute > Applied Physiology Research Center
Cardiovascular Research Institute > Isfahan Cardiovascular Research Center
Faculty of Medicine > Department of Basic Science > Department of Medical Physics
Other
Page Range: E229-E234
Journal or Publication Title: American Journal of Therapeutics
Journal Index: ISI
Volume: 27
Number: 3
Identification Number: https://doi.org/10.1097/MJT.0000000000000875
ISSN: 1075-2765
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/12616

Actions (login required)

View Item View Item